The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia
- 26 January 2012
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 119 (4), 911-923
- https://doi.org/10.1182/blood-2011-07-366203
Abstract
An important mediator of cytokine signaling implicated in regulation of hematopoiesis is the PI3K/protein kinase B (PKB/c-Akt) signaling module. Constitutive activation of this signaling module has been observed in a large group of leukemias. Because activation of this signaling pathway has been demonstrated to be sufficient to induce hematologic malignancies and is thought to correlate with poor prognosis and enhanced drug resistance, it is considered to be a promising target for therapy. A high number of pharmacologic inhibitors directed against either individual or multiple components of this pathway have already been developed to improve therapy. In this review, the safety and efficacy of both single and dual-specificity inhibitors will be discussed as well as the potential of combination therapy with either inhibitors directed against other signal transduction molecules or classic chemotherapy.Keywords
This publication has 170 references indexed in Scilit:
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and StressMolecular Cell, 2010
- The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulationCancer, 2010
- Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancerOncogene, 2010
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4ECancer Cell, 2010
- Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicingLeukemia Research, 2009
- The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemiasBritish Journal of Cancer, 2008
- Inositol 1,3,4,5-Tetrakisphosphate Negatively Regulates Phosphatidylinositol-3,4,5- Trisphosphate Signaling in NeutrophilsImmunity, 2007
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000